NewAmsterdam Pharma Files 8-K on Officer/Director Changes
Ticker: NAMSW · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1936258
| Field | Detail |
|---|---|
| Company | Newamsterdam Pharma CO N.V. (NAMSW) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
NewAmsterdam Pharma 8-K: Director/Officer changes and compensation details filed July 11, 2025.
AI Summary
On July 11, 2025, NewAmsterdam Pharma Co N.V. filed an 8-K report detailing the departure of directors or certain officers, the election of directors, and the appointment of certain officers. The filing also covers compensatory arrangements for certain officers and includes financial statements and exhibits. The company, formerly known as NewAmsterdam Pharma Co B.V., is incorporated in The Netherlands.
Why It Matters
This filing provides crucial updates on the company's leadership and governance structure, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes and does not indicate any immediate financial distress or significant operational shifts.
Key Players & Entities
- NewAmsterdam Pharma Co N.V. (company) — Registrant
- NewAmsterdam Pharma Co B.V. (company) — Former company name
- July 11, 2025 (date) — Date of report
FAQ
What specific officer or director positions were affected by the changes reported in the 8-K?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided excerpt.
Are there any details about the compensatory arrangements for the officers mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item covered, but the specific details of these arrangements are not provided in the excerpt.
When did NewAmsterdam Pharma Co N.V. change its name from NewAmsterdam Pharma Co B.V.?
The date of the name change from NewAmsterdam Pharma Co B.V. to NewAmsterdam Pharma Co N.V. was July 1, 2022.
What is the primary business of NewAmsterdam Pharma Co N.V. according to the SIC code?
The Standard Industrial Classification (SIC) code provided is 2834, which corresponds to 'PHARMACEUTICAL PREPARATIONS'.
Where is NewAmsterdam Pharma Co N.V. incorporated and what is its principal business address?
The company is incorporated in The Netherlands, and its business address is Gooimeer 2-35, Naarden, The Netherlands, 1411 DC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding NewAmsterdam Pharma Co N.V. (NAMSW).